Industry › BioTech
Press Releases
Novotech Acquires European CRO, Strengthens Global Operations
Novotech Health Holdings Pte Ltd
Jan 12, 2023 15:00 HKT/SGT
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Novotech Health Holdings Pte Ltd
Jan 12, 2023 15:00 HKT/SGT
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)
HighTide Therapeutics Inc.
Jan 11, 2023 21:00 HKT/SGT
Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program
Avance Clinical
Jan 11, 2023 15:00 HKT/SGT
Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Europe
Eisai
Jan 11, 2023 11:52 HKT/SGT
Prenetics旗下的行动基因的ACTOnco® IVD产品获得FDA许可 成为首家就适用于所有实体肿瘤的癌症基因检测取得许可的亚洲公司
Prenetics Global Limited
Jan 11, 2023 11:21 HKT/SGT
Prenetics旗下的行動基因的ACTOnco® IVD產品獲得FDA許可 成為首家就適用於所有實體腫瘤的癌症基因檢測取得許可的亞洲公司
Prenetics Global Limited
Jan 11, 2023 11:20 HKT/SGT
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
Prenetics Global Limited
Jan 11, 2023 11:19 HKT/SGT
君聖泰HTD1801治療非酒精性脂肪性肝炎（NASH）的臨床IIb 期研究（CENTRICITY研究）完成首例患者給藥
HighTide Therapeutics Inc.
Jan 11, 2023 08:01 HKT/SGT
君圣泰HTD1801治疗非酒精性脂肪性肝炎（NASH）的临床IIb 期研究（CENTRICITY研究）完成首例患者给药
HighTide Therapeutics Inc.
Jan 11, 2023 08:00 HKT/SGT
